home / stock / lobe:cc / lobe:cc news

LOBE:CC News and Press, Lobe Sciences Ltd. From 08/10/22

Stock Information
Company Name: Lobe Sciences Ltd.
Stock Symbol: LOBE:CC
Market: CNQC
Website: lobesciences.com
Menu
LOBE:CC LOBE:CC Quote LOBE:CC Short LOBE:CC News LOBE:CC Articles LOBE:CC Message Board
Get LOBE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
LOBE:CC - Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia

Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced...
LOBE:CC - Lobe Sciences Files Patent Application Covering the Preparation of Stable Psilocin Prodrugs and Analogues and their Uses Further Strengthening its Intellectual Property Portfolio

Vancouver, British Columbia--(Newsfile Corp. - July 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced i...

LOBE:CC - Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023

Vancouver, British Columbia--(Newsfile Corp. - July 7, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biotechnology company committed to discovering and developing psychedelic derived medicines today announced it has developed its initial Phase 1 st...

LOBE:CC - Lobe Sciences Ltd. and Clearway Global LLC Enter into a Development Agreement to Manage Lobe Sciences Ltd.'s Global Regulatory and Development Strategy and its Implementation

Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopsychedelics company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and mental...
LOBE:CC - Lobe Sciences Announces Roadmap for Remainder of 2022 and Early 2023

Vancouver, British Columbia--(Newsfile Corp. - June 14, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"), a Canadian Biopharmaceutical Company committed to discovering and developing psychedelic inspired medicines for the improvement of neurologic, brain and me...

LOBE:CC - IIROC Trade Resumption - LOBE

IIROC Trade Resumption - LOBE Canada NewsWire VANCOUVER, BC , June 9, 2022 /CNW/ - Trading resumes in: Company: Lobe Sciences Ltd. CSE Symbol: LOBE All Issues: Yes Resumption (ET): 9:30 AM 06/10/22 IIROC can make a decision to impose a...

LOBE:CC - CSE Bulletin: Consolidation - Lobe Sciences Ltd. (LOBE)

Toronto, Ontario--(Newsfile Corp. - Le 9 juin/June 2022) - Lobe Sciences Ltd. (the "Issuer") has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares. As a result, the o...
LOBE:CC - Lobe Sciences Ltd Announces Change in Record Date of Share Consolidation

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company") announces that further to the Company's June 6, 2022, news release, the record date for the six for one consolidation has been adjusted to June 10, 2022. The ...

LOBE:CC - IIROC Trading Halt - LOBE

IIROC Trading Halt - LOBE Canada NewsWire VANCOUVER, BC , June 9, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Lobe Sciences Ltd. CSE Symbol: LOBE All Issues: Yes Reason: Pending Clarification of News H...

LOBE:CC - Lobe Sciences Announces Share Consolidation

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) (" Lobe " or the " Company ") announces that its board of directors has authorized the implementation of a consolidation (the " Consolidation ") of the Company's common shares (the " Sh...
Previous 10 Next 10